Marsh & McLennan Companies, Inc. (MRSH)
Valuation Overview•Is Marsh & McLennan Companies, Inc. Overvalued or Undervalued?
Trading at a discount to intrinsic cash flow value, implying pessimistic long-term market expectations.
Moderate quality score of 68/100, reflecting stable operating margins and manageable leverage.
Analysts remain bullish, forecasting further upside expansion with consensus targets suggesting solid gains.
Confirm your valuation thesis with live pattern overlays, key pivot levels, and AI trade plans.
Verdict: Solid fundamental quality, though solvency presents a headwind.
Wall Street is broadly bullish, projecting solid upside alongside robust expected earnings growth. This is paired with healthy capital returns, driven by a balanced mix of reliable dividends and share buybacks.
MRSH exhibits elite business quality, driven by exceptional capital efficiency and highly lucrative margins. However, the balance sheet carries elevated leverage, requiring careful monitoring of debt servicing capabilities.
The company demonstrates solid revenue growth (9.2% 3Y CAGR) paired with robust earnings compounding (11.8% EPS 3Y CAGR). The company maintains healthy operational efficiency with a 21.4% operating margin.
| Financial Metric | Trend (12Q) | Latest Qtr | 1Y Growth | 3Y CAGR | 5Y CAGR | 10Y CAGR |
|---|---|---|---|---|---|---|
| Revenue | $6.9B | +10.3% | +9.2% | +9.4% | +7.7% | |
| EBITDA | $1.4B | — | +12.6% | — | — | |
| Net Income | $808.0M | +2.5% | +10.9% | — | +10.0% | |
| EPS (Diluted) | $1.69 | +3.1% | +11.8% | +16.4% | +11.0% | |
| Free Cash Flow | $1.4B | +25.5% | +18.6% | +10.5% | — |
| Metric | TTM | 3Y Avg | 5Y Avg | 10Y Avg |
|---|---|---|---|---|
| Gross Margin | 42.8% | 42.5% | 42.3% | 42.1% |
| Operating Margin | 21.4% | 23.4% | 22.5% | 20.2% |
| Net Margin | 14.2% | 16.2% | 15.8% | 13.6% |
| FCF Margin | 14.6% | 17.2% | 16.4% | 15.0% |
| Quarter | EPS Est. | EPS Act. | Surprise | EPS | Rev |
|---|---|---|---|---|---|
| Q1'26Latest | $1.97 | $1.87 | -5.1% | ||
| Q4'25 | $1.78 | $1.85 | +3.9% | ||
| Q3'25 | $2.67 | $2.72 | +1.9% | ||
| Q2'25 | $3.02 | $3.06 | +1.3% | ||
| Q1'25 | $1.79 | $1.87 | +4.5% | ||
| Q4'24 | $1.61 | $1.63 | +1.2% | ||
| Q3'24 | $2.40 | $2.41 | +0.4% | ||
| Q2'24 | $2.80 | $2.89 | +3.2% |
Total return is +0.7% (1Y), lagging the benchmark by -9.0%
| Period | Total Return | vs S&P 500 (Alpha) | Dividend Contribution |
|---|---|---|---|
| YTD | -2.5% | -10.2% | — |
| 1Y | +0.7% | -9.0% | +2.1% |
| 3YCAGR | -1.8% | -20.9% | +5.3% |
| 5YCAGR | +2.9% | -6.5% | +9.2% |
| 10YCAGR | +11.8% | -1.4% | — |
The S&P 500 is at 29.9x trailing P/E — Expensive relative to historical averages.
Quick answers to common questions about Marsh & McLennan Companies, Inc. (MRSH) valuation, health, and returns.
Marsh & McLennan Companies, Inc. is estimated to be undervalued under our discounted cash flow framework. relative multiples indicate the stock is Fair versus peers compared to industry peers. undervalued (implying +57.9% upside to DCF intrinsic value of $274.88)
Marsh & McLennan Companies, Inc. has multiple valuation anchors: DCF Intrinsic Value: $274.88 | Peer Relative Fair Value: $182.51 | Wall Street Analyst Target: $199.40 (implying +14.6% upside). A convergence of these signals offers higher conviction.
Marsh & McLennan Companies, Inc. displays good financial health with a composite quality score of 68/100, supported by a Piotroski F-Score of 6/9, Return on Invested Capital (ROIC) of 13.9%.
Marsh & McLennan Companies, Inc. pays a 1.7% dividend yield, covered by a 41% payout ratio with 16 years of growth, supplemented by a 2.1% buyback yield.
Marsh & McLennan Companies, Inc.'s current growth trajectory is Stable. The company achieved +10.3% 1Y revenue growth and +3.1% 1Y EPS growth, compared to its 3Y revenue CAGR of +9.2%.
Wall Street consensus is Hold based on 26 analysts, beating EPS expectations in 92% of recent quarters with a -1-quarter streak. The consensus price target represents a +14.6% change from current levels.
Investment risks for Marsh & McLennan Companies, Inc. include: -9.8% 1-year max drawdown. Volatility risk is characterized by a beta of -0.10x.
No. These computations are purely quantitative model outputs for informational purposes. They do not account for qualitative management shifts or macro events. Always consult a licensed RIA before buying or selling shares.
Disclaimer: This page is for informational purposes only and does not constitute financial advice. All valuation models, scores, and target estimates are automated computations under stated assumptions and should not be relied upon as the sole basis for any investment decision.